MUSTANG BIO, INC. Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate
MUSTANG BIO, INC. (MBIO) had Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate of 2.00% as of 2019-03-29, per its 10-Q filed 2019-08-09.
Discontinued › Notes › Debt
us-gaap:LongTermDebtPercentageBearingFixedInterestRate · last filed 2019-08-09
- 2019-03-29: Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate 2.00%.
| Period end | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate |
|---|---|
| 2019-03-29 | 2.00% 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |